221 related articles for article (PubMed ID: 27382975)
1. Imidazoline scaffold in medicinal chemistry: a patent review (2012-2015).
Sączewski F; Kornicka A; Balewski Ł
Expert Opin Ther Pat; 2016 Sep; 26(9):1031-48. PubMed ID: 27382975
[TBL] [Abstract][Full Text] [Related]
2. Imidazoline derivatives: a patent review (2006--present).
Guan X; Hu Y
Expert Opin Ther Pat; 2012 Nov; 22(11):1353-65. PubMed ID: 23003008
[TBL] [Abstract][Full Text] [Related]
3. Biologically active compounds based on the privileged 2-imidazoline scaffold: The world beyond adrenergic/imidazoline receptor modulators.
Krasavin M
Eur J Med Chem; 2015 Jun; 97():525-37. PubMed ID: 25466925
[TBL] [Abstract][Full Text] [Related]
4. Significance of the imidazoline receptors in toxicology.
Lowry JA; Brown JT
Clin Toxicol (Phila); 2014 Jun; 52(5):454-69. PubMed ID: 24666288
[TBL] [Abstract][Full Text] [Related]
5. Deciphering Imidazoline Off-targets by Fishing in the Class A of GPCR field.
Djikic T; Vucicevic J; Laurila J; Radi M; Veljkovic N; Xhaard H; Nikolic K
Mol Inform; 2020 Jul; 39(7):e1900165. PubMed ID: 32078760
[TBL] [Abstract][Full Text] [Related]
6. Methylation of imidazoline related compounds leads to loss of α₂-adrenoceptor affinity. Synthesis and biological evaluation of selective I₁ imidazoline receptor ligands.
Schann S; Greney H; Gasparik V; Dontenwill M; Rascente C; Lacroix G; Monassier L; Bruban V; Feldman J; Ehrhardt JD; Bousquet P
Bioorg Med Chem; 2012 Aug; 20(15):4710-5. PubMed ID: 22750139
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and CoMFA studies of N1-amino acid substituted 2,4,5-triphenyl imidazoline derivatives as p53-MDM2 binding inhibitors.
Hu C; Dou X; Wu Y; Zhang L; Hu Y
Bioorg Med Chem; 2012 Feb; 20(4):1417-24. PubMed ID: 22273545
[TBL] [Abstract][Full Text] [Related]
8. Effects of imidazoline and non-imidazoline α-adrenergic agents on rabbit platelet aggregation.
Yokota S; Hikasa Y; Mizushima H
Pharmacology; 2013; 91(3-4):135-44. PubMed ID: 23364471
[TBL] [Abstract][Full Text] [Related]
9. Bis(2-aminoimidazolines) and Bisguanidines: Synthetic Approaches, Antiparasitic Activity and DNA Binding Properties.
Dardonville C; Martínez JJN
Curr Med Chem; 2017; 24(33):3606-3632. PubMed ID: 28641558
[TBL] [Abstract][Full Text] [Related]
10. 2,4,5-Tris(alkoxyaryl)imidazoline derivatives as potent scaffold for novel p53-MDM2 interaction inhibitors: Design, synthesis, and biological evaluation.
Bazanov DR; Pervushin NV; Savitskaya VY; Anikina LV; Proskurnina MV; Lozinskaya NA; Kopeina GS
Bioorg Med Chem Lett; 2019 Aug; 29(16):2364-2368. PubMed ID: 31196710
[TBL] [Abstract][Full Text] [Related]
11. Novel ligands rationally designed for characterizing I2-imidazoline binding sites nature and functions.
Gentili F; Cardinaletti C; Vesprini C; Ghelfi F; Farande A; Giannella M; Piergentili A; Quaglia W; Mattioli L; Perfumi M; Hudson A; Pigini M
J Med Chem; 2008 Aug; 51(16):5130-4. PubMed ID: 18661965
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activities of 2-[(heteroaryl)methyl]imidazolines.
Saczewski J; Hudson A; Scheinin M; Rybczynska A; Ma D; Saczewski F; Laird S; Laurila JM; Boblewski K; Lehmann A; Gu J; Watts H
Bioorg Med Chem; 2012 Jan; 20(1):108-16. PubMed ID: 22172308
[TBL] [Abstract][Full Text] [Related]
13. A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus.
Mammoli V; Bonifazi A; Dal Ben D; Giannella M; Giorgioni G; Piergentili A; Pigini M; Quaglia W; Thomas A; Newman AH; Ferré S; Sanchez-Soto M; Keck TM; Del Bello F
ChemMedChem; 2016 Aug; 11(16):1819-28. PubMed ID: 26990230
[TBL] [Abstract][Full Text] [Related]
14. Isothiazolidinone inhibitors of PTP1B containing imidazoles and imidazolines.
Douty B; Wayland B; Ala PJ; Bower MJ; Pruitt J; Bostrom L; Wei M; Klabe R; Gonneville L; Wynn R; Burn TC; Liu PC; Combs AP; Yue EW
Bioorg Med Chem Lett; 2008 Jan; 18(1):66-71. PubMed ID: 18037290
[TBL] [Abstract][Full Text] [Related]
15. QSAR study of imidazoline antihypertensive drugs.
Nikolic K; Filipic S; Agbaba D
Bioorg Med Chem; 2008 Aug; 16(15):7134-40. PubMed ID: 18621536
[TBL] [Abstract][Full Text] [Related]
16. Investigations on the effects of basic side chains on the hormonal profile of (4R,5S)/(4S,5R)-4,5-bis(4-hydroxyphenyl)-2-imidazolines.
von Rauch M; Busch S; Gust R
J Med Chem; 2005 Jan; 48(2):466-74. PubMed ID: 15658860
[TBL] [Abstract][Full Text] [Related]
17. Theoretical study of structure, pKa, lipophilicity, solubility, absorption, and polar surface area of some centrally acting antihypertensives.
Remko M; Swart M; Bickelhaupt FM
Bioorg Med Chem; 2006 Mar; 14(6):1715-28. PubMed ID: 16263295
[TBL] [Abstract][Full Text] [Related]
18. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
Molderings GJ; Likungu J; Jakschik J; Göthert M
Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
[TBL] [Abstract][Full Text] [Related]
19. Substituted oxadiazoles: a patent review (2010 - 2012).
Zarghi A; Hajimahdi Z
Expert Opin Ther Pat; 2013 Sep; 23(9):1209-32. PubMed ID: 23663160
[TBL] [Abstract][Full Text] [Related]
20. Imidazoline binding sites and their ligands: an overview of the different chemical structures.
Dardonville C; Rozas I
Med Res Rev; 2004 Sep; 24(5):639-61. PubMed ID: 15224384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
